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Background   There is a 5- to 8-fold increased risk of mortality 
during the first 3 months after a hip fracture. Several risk factors 
are known. We studied the predictive value (for mortality) of rou-
tine blood tests taken on admission.
Methods   792 hip fracture patients were included prospectively; 
blood tests were taken on admission. Follow-up data on mortality 
were obtained from the civil registration system. Patients were 
divided into 2 groups based on whether they had survived at least 
90 days after the hip fracture. To estimate which laboratory tests 
could be used to predict outcome, we used receiver operation 
characteristic (ROC) curves.
Results   3-month mortality could be predicted with 69% accu-
racy from the level of plasma creatinine in standard admission 
blood tests. The mortality in patients with elevated levels of creati-
nine was almost 3-fold that of the patients with normal creatinine. 
Mortality was also associated with age, low blood hemoglobin, 
high plasma potassium, and low plasma albumin levels.
Interpretation   Our findings could be of use in identifying 
patients who might benefit from increased attention periopera-
tively.

With the increasingly large proportion of elderly individuals 
in our populations, the hip fracture incidence curve is shift-
ing to the right and hip fracture patients are becoming a more 
heterogeneous group (Bergström et al. 2009). Almost all 
excess mortality occurs within the first 3 months after sur-
gery (Petersen et al. 2006). A large meta-analysis has found 
a 5- to 8-fold increased risk of mortality during this period 
(Haentjens et al. 2010). Several factors that may be predictive 
of death have been identified (Petersen et al. 2006). We stud-
ied the predictive value (for mortality) of routine blood tests.
Patients and methods
792 hip fracture patients aged 60 or older who were admitted 
to the Department of Orthopedics, Bispebjerg University Hos-
pital, Denmark from October 2008 through July 2010 were 
included prospectively. 67 patients aged less than 60 were 
excluded. Follow-up data on mortality were obtained from 
the civil registration system on August 1, 2010. Patients were 
included in the study within the first 3 days after admission. 
Because of various logistical problems, not all blood tests 
were done for some patients in the study (Table 1). The patients 
were divided into 2 groups based on whether they survived for 
at least 90 days after the hip fracture.
 The study was approved by the local ethics committee and 
by the Danish data protection agency, and it was carried out in 
line with the Helsinki Declaration.
Statistics
Continuous variables are presented as mean (SD) or median 
(range). We used student’s t-test for continuous, normally 
distributed variables, Mann-Whitney 2-sample statistics for 
skewed distributions, and Chi-squared test to compare cat-
egorical variables. To estimate which laboratory tests could be 
used to predict outcome, we used receiver operation charac-
teristic (ROC) curves and calculated the area under the curve 
(AUC) for the different tests. Cutoff values for the different 
laboratory tests were predicted using ROC curves or based 
on the test performance in a normal cohort. Univariate and 
multivariate logistic regression analyses were used to examine 
the relationship between the various risk factors and outcome. 
Values of p < 0.05 were considered statistically significant. 
Data were analyzed using STATA software. 32  Acta Orthopaedica 2012; 83 (1): 31–35
Results
232 of 792 patients (29%) died during the study period (Table 
1), at median 44 (1–582) days. 57 died between 1 and 66 
days, while still in hospital. 106 died after leaving hospital 
but within 3 months, and 69 died some time after 3 months. 
Based on the ROC curves (Figure 1), the cutoff values were 
set at 7 mmol/L in both sexes for hemoglobin and above 50 
mg/L for C-reactive protein (CRP). The ROC curves for most 
other laboratory tests did not indicate any optimal cutoff value 
(the number of correctly classified patients was the same for 
a large variety of values) (Table 2). We therefore decided to 
use the upper or lower limits of normal laboratory reference     
intervals as cutoff values. 
In the univariate analysis (Table 3), high age, high plasma 
creatinine (Figure 2), low plasma albumin, high plasma potas-
sium, and low blood hemoglobin led to increased mortality. 
Patient mortality was not related to gender, blood platelet 
Table 1. Characteristics of the cohort and blood sample values at the time of admission
  Hip fracture patients  
  Number of  Survived study  Died during  p-value
  patients  period  study period
Number   792  560  232 
Age, mean (SD)     
  Women  591  83 (9)  87 (8)  < 0.001
  Men  201  78 (9)  83 (9)  < 0.001
Sex, n (%)     
  Women  591  425 (76%)  166 (72%)
  Men  201   135 (24%)    66 (28%)  0.2
Blood hemoglobin (mmol/L), mean (SD).
Reference interval: women: 7.3–9.5 mmol/L, 
  men: 8.5–10.3 mmol/L     
  Women  590  7.5 (1.1)   7.3 (1.0)  0.02
  Men  201  8.0 (1.2)   7.2 (1.2)   < 0.001
Plasma creatinine (μmol/L), median (range).
Ref. int.: women: 50–90 μmol/L, 
  men: 60–105 μmol/L     
  Women  585  68 (33–445)    82 (36–615)   < 0.001
  Men  200  82 (39–419)  106 (50–699)  < 0.001
Plasma sodium (mmol/L), mean (SD).
Ref. int.: 137–144 mmol/L     
  Women  587  137 (4.1)  137 (5.1)  0.4
  Men  201  138 (4.3)  138 (4.6)   0.5
Plasma potassium (mmol/L), mean (SD).
Ref. int.: 3.5–4.6 mmol/L     
  Women  587  3.8 (0.49)  4.0 (0.67)  0.002
  Men  201  4.0 (0.49)   4.1 (0.59)  0.2
Plasma glucose (mmol/L), mean (SD). 
Ref. int.: 4.2–7.2 mmol/L     
  Women  556  6.8 (2.1)  6.5 (1.7)  0.1
  Men  185  6.6 (2.3)  6.8 (2.1)  0.5
Plasma albumin (g/L), mean (SD).
Ref. int.: 34–45 g/L     
  Women  515  39 (4.4)  37 (5.4)  < 0.001
  Men  174  39 (4.7)  36 (5.6)  0.003
Plasma CRP (mg/L), median (range).
Ref. int.: < 10 mg/L     
  Women  458  67 (82)  71 (73)  0.05
  Men  170  66 (70)  81 (86)  0.2
Leukocyte count (× 109/L), mean (SD).
Ref. int.: 3.5–8.8 × 109/L    
  Women  590  11.0 (4.0)  10.8 (4.1)  0.7
  Men  201  11.5 (5.6)  10.5 (4.3)  0.1
Platelet count (× 109/L), mean (SD).
Ref. int.: 145–390 × 109/L    
  Women  590  249 (86)  270 (80)  0.007
  Men  201  229 (79)  240 (90)  0.4
Blood was analyzed for hematology and chemistry using Sysmex (Sysmex Corporation, Kobe City, Japan) 
and Vitros 5.1 FS (Ortho-Clinical Diagnostics, Pisataway, NJ) respectively, using standardized routine labora-
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count, or CRP. After adjustment in the multivariate logistic 
regression model, age, plasma creatinine, plasma potassium, 
plasma albumin remained as risk factors.
Discussion
Previous studies on mortality after hip fracture have found an 
association with plasma creatinine levels (Lewis et al. 2006, 
Singh et al. 2008, Björkelund et al. 2009, Bennet et al. 2010, 
Ho et al. 2010), which is what we found in the present study. 
Of these previous studies, the most comprehensive was a pro-
spective observational study of 2,963 consecutive patients by 
Lewis et al. (2006). They found that serum urea was an inde-
pendent predictor of mortality at 30 and 90 days, and also at 1 
and 2 years. Furthermore, mortality was also higher in patients 
admitted with raised or low serum sodium, raised serum potas-
sium, and raised serum creatinine. A prospective cohort study 
of 436 patients in Sweden found that in bivariate analysis, a 
creatinine concentration of more than 100 umol/L on admis-
sion was a risk factor for poor 4-month survival. Using mul-
tiple logistic regression analysis, creatinine was not found to 
be an independent risk factor (Björkelund et al. 2009). 
In both of the above-mentioned studies, the cutoff value for 
elevated creatinine was set differently than in our study, and 
it appears that the same value was used for both sexes. In our 
study, the cutoff level for elevated serum creatinine was set at 
105 μmol/L for men and 90 μmol/L for women, as these are 
the upper limits of 95% CI in normal Scandinavian subjects 
(Felding et al. 2004). 
A recent Norwegian study on 364 hip fracture patients found 
that the use of diuretics, followed by the presence of conges-
tive heart disease on admission, were the strongest predictors 
of 1-year mortality (Juliebø et al. 2010). These findings sug-
gest that the increased mortality in patients with elevated cre-
Table 2. Area under the curve (AUC) for the routine laboratory tests 
included in the study
  Area under ROC a SE  b   95% CI
Plasma creatinine  0.69  0.02  0.64–0.74
Plasma potassium  0.61  0.02  0.55–0.66
Blood hemoglobin  0.60  0.02  0.55–0.65
Plasma albumin  0.59  0.02  0.53–0.64
Blood platelet count  0.58  0.02  0.53–0.63
Plasma CRP  0.55  0.02  0.50–0.60
Blood glucose  0.52  0.02  0.47–0.57
Blood leukocyte count  0.52  0.02  0.47–0.57
Plasma sodium  0.51  0.02  0.46–0.56
a Receiver operating curve
b standard error
Figure 1. ROC curves for prediction of mortality in relation to labo-
ratory values at admission. The curves represent plasma creatinine 
(crea, solid line), inverse blood hemoglobin (hb, dashed line), and 
plasma potassium (K, dotted line). Hemoglobin values were converted 
because the association with death followed decreasing values.
Figure 2. Kaplan Meier plot: mortality in relation to creatinine levels at admission. 3-month mortality after hip 
fracture. The plot on the left is divided into groups with elevated plasma creatinine (dotted line) and normal 
plasma creatinine (solid line). Plasma creatinine was elevated if above 105 μmol/L in males and 90 μmol/L in 
females. The plot on the right is divided into quartiles of plasma creatinine. 34  Acta Orthopaedica 2012; 83 (1): 31–35
atinine may be due to congestive heart disease that is severe or 
poorly regulated. The added strain of hospitalization and sur-
gery may lead to the increased mortality. Concerning serum 
albumin, several previous studies have found it to be associ-
ated with mortality after hip fractures (Koval et al. 1999, Pioli 
et al. 2006, O’Daly et al. 2010, Pimlott et al. 2011, Oztürk et 
al. 2010).
A recent retrospective study of 200 patients (O’Daly et al. 
2010) suggested that serum albumin at admission and total 
lymphocyte count could serve as markers of malnutrition and 
could be used to predict clinical outcome after hip fractures. 
However, only levels of albumin at admission and age were 
found to be independent prognostic factors for 1-year mor-
tality by Cox regression analysis, with hazard ratios of 0.93 
(95% CI: 0.89–0.98; p = 0.007) and 1.04 (95% CI: 1.007–
1.07; p = 0.02) respectively. In the same study, patients with 
low albumin at admission had an odds ratio of 4.0 (95% CI: 
1.3–12.2; p = 0.02) for dying within 3 months of the frac-
ture (as compared to patients with normal albumin levels). 
In a similar study (Koval et al. 1999), patients were regarded 
as being malnourished based on total lymphocyte count and 
albumin levels at admission. Patients with reduced values for 
both parameters on admission were 3.5 times more likely to 
die within 1 year of surgery (p < 0.01).
A recent study from Canada of 583 hip fracture patients 
found an association between low serum albumin levels at 
admission and in-hospital mortality (Pimlott et al. 2010). After 
multivariate adjustment, an association between low serum 
albumin and mortality was found to be statistically signifi-
cant with an adjusted OR of 2.4 (95% CI: 1.2–5.1; p < 0.05). 
Almost half of the hip fracture patients had low serum albu-
min at the time of admission and it was independently associ-
ated with 2.5-fold greater odds of short-term mortality.
The association between mortality after hip fracture and 
reduced hemoglobin levels at admission has also been 
reported in previous studies (Gruson et al. 2002, Halm et al. 
2004, Bhaskar and Parker 2011). In a American study of 548 
hip fracture patients (Halm et al. 2004), 60-day mortality after 
hip fracture was associated with admission levels of hemoglo-
bin, giving an adjusted odds ratio of 0.69 (95% CI: 0.49–0.95; 
p < 0.05). The authors theorized that the degree of anemia is a 
marker of underlying comorbid illness burden and physiologi-
cal reserve. A study on 395 patients found that patients with 
anemia on admission were more likely to die within 6 or 12 
months of hip fracture surgery (Gruson et al. 2002). The sever-
ity of anemia was associated with an increased risk of mortal-
ity. In the same study, anemia on admission was not predictive 
of 3-month mortality, but was predictive of mortality at 6 and 
12 months after hip fracture. 
The strength of our study is that the mortality data has been 
validated. However, we have no information on the cause of 
death. It is uncertain whether preoperative correction of ele-
vated serum creatinine levels would be beneficiary, but we are 
currently planning studies to investigate this. 
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